Stay updated on SPR1NT Clinical Trial
Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.

Latest updates to the SPR1NT Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoChange DetectedThe page has removed an erratum related to the clinical trial and postmarketing safety of Onasemnogene Abeparvovec Therapy.SummaryDifference0.3%
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new identifiers and collaborators related to the study of Spinal Muscular Atrophy (SMA), while extensive details about the study's methodology and inclusion/exclusion criteria have been removed.SummaryDifference35%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to SPR1NT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.